NEW YORK--(BUSINESS WIRE)--The Board of Directors of Marsh McLennan (NYSE: MMC) today authorized the renewal of the Company's share repurchase program, allowing management to buy back up to $6 billion of the Company's common stock going forward, which supersedes any prior authorization. About Marsh McLennan Marsh McLennan (NYSE: MMC) is a global leader in risk, strategy and people, advising clients in 130 countries across four businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman. With annu.

Jim Stewart, NYT columnist, joins 'The Exchange' to discuss the bidding happening for Warner Bros. Discovery, if bidders will end up overpaying and much more.

Ayako Yoshioka, portfolio consulting director at Wealth Enhancement Group, says AI-related valuations are reasonable. She discusses how Nvidia's earnings are being digested by investors with Caroline Hyde and Ed Ludlow on “Bloomberg Tech.

LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”).

LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming December 29, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) common stock between March 5, 2024 and October 28, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR AVANTOR INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.

CNBC's Deirdre Bosa reports on news regarding Alphabet.

LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming December 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Marex Group plc (“Marex” or the “Company”) (NASDAQ: MRX) securities between May 16, 2024 and August 5, 2025, inclusive (the “Class Period”).

It's not the time to bet against the biggest US technology names, short-seller Carson Block tells Kriti Gupta, even as warnings rise about a potential bubble in artificial intelligence https://www.bloomberg.com/news/articles/2025-11-20/muddy-waters-block-says-it-s-not-the-time-to-short-big-tech

Astera Labs rises on soaring hyperscaler demand as its Connectivity Platform powers next-gen AI data centers, but sustaining this momentum poses key challenges.

LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming December 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired WPP plc (“WPP” or the “Company”) (NYSE: WPP) common stock between February 27, 2025 and July 8, 2025, inclusive (the “Class Period”).

Nayax Ltd. remains a Buy as Q3 results confirm strong fundamentals, with robust recurring revenue and improving margins driving long-term growth potential. NYAX's recurring revenue engine, now 73.9% of total revenue, is supported by expansion into higher-ticket verticals like EV charging and amusement. Gross margin expansion and operating leverage are enhancing profitability, supporting management's ambitious 2028 targets for revenue growth and EBITDA margin.

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Western Alliance Bancorporation (NYSE: WAL) resulting from allegations that Western Alliance Bancorporation may have issued materially misleading business information to the investing public.

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public.

WMT lifts its FY26 outlook after Q3 revenues and earnings beat estimates, powered by rapid e-commerce growth and solid segment performance.

V gains momentum as Cash App and Afterpay pilot a new pay-over-time debit feature that runs across its network.

Legendary investor Bill Ackman disclosed no new stock purchases in the third quarter, instead showing a decreased position in shares of Magnificent Seven stock Alphabet Inc (NASDAQ: GOOG)(NASDAQ: GOOGL). With Alphabet hitting new all-time highs since the end of the third quarter, Ackman missed out on millions in potential profits.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In WPP To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in WPP between February 27, 2025 and July 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against WPP plc (“WPP” or the “Company”) …

BELLEVUE, Wash.--(BUSINESS WIRE)--T-Mobile (NASDAQ: TMUS) today announced a multi-year extension as the Exclusive 5G Partner of the FORMULA 1 HEINEKEN LAS VEGAS GRAND PRIX and an expansion to become the Regional 5G Innovation Partner of Formula 1®, underscoring T-Mobile's role as a leading technology and fan experience partner for one of the world's most high-profile sporting organizations. Under the new agreement, T-Mobile will bring 5G-connected technologies supporting broadcast innovations a.

Sessions with AcariaHealth, the National Association of Specialty Pharmacy (NASP), and Reuters Events deliver actionable insights on biosimilar adoption, patient access, and specialty pharmacy readiness ORLANDO, Fla. , Nov. 20, 2025 /PRNewswire/ -- AcariaHealth, a leading specialty pharmacy and a company of Centene Corporation (NYSE: CNC), announced the completion of three national educational events in October focused on the evolving U.S. biosimilars landscape.

RADNOR, Pa., Nov. 20, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that an amended securities class action lawsuit has been filed against CarMax, Inc. (“CarMax”) (NYSE: KMX) which expands the class period to include those who purchased or otherwise acquired CarMax securities between June 20, 2025, and November 5, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is January 2, 2026.